Regen RX Therapy in Atlanta, Georgia, offers non-surgical treatments spanning skin therapy, IV drips and aesthetic therapy. For readers searching for “lip filler in atlanta Regen RX,” the business provides a starting point for discussing those broader categories, but its supplied service information does not establish a specific lip-filler offering. That distinction matters in examining both the business’s public-facing description and the national treatment statistics that can inform, but cannot measure, Atlanta’s local market.

An East Shadowlawn Address Anchors Regen RX Therapy’s Atlanta Presence

Regen RX Therapy lists its address as 3134 East Shadowlawn Avenue Northeast, Atlanta, GA, 30305-2406. Its description places skin therapy, IV drips and aesthetic therapy within a non-surgical treatment offering, alongside an invitation to explore wellness options. The website also carries the labels “Experience Beauty Therapy,” “Our Services,” “Our Products,” “Buckhead Location” and “Decatur Location.” These are the available building blocks for describing the business: a named Atlanta address, broad treatment categories, product information and location references. They should not be stretched into a detailed clinical menu. In particular, a reference to aesthetic therapy is not, on its own, confirmation of every procedure that a prospective customer might associate with that category.

The distinction between a category and an individual treatment is central to an accurate account of this business. “Our Products” identifies a website section, but does not establish particular brands or formulations. Similarly, the Buckhead and Decatur labels identify location-related information without supplying a second street address in the verified material. Regen RX Therapy provides a telephone number, 678.973.0866, and an email address, info@regenrxtherapy.com. Those contact details give readers a direct route for seeking clarification rather than relying on assumptions drawn from search terms. The available facts support a profile of a business offering several non-surgical treatment categories; they do not support claims about its treatment volume, staffing, operating history or share of Atlanta’s aesthetic market.

National Filler Totals Leave Atlanta’s Lip-Treatment Market Unmeasured

The American Society of Plastic Surgeons’ 2024 Plastic Surgery Statistics Report recorded 5,331,426 hyaluronic-acid filler treatments nationally, an increase of 1% from 2023. The report also stated that patients aged 40–54 accounted for 50% of those treatments. These are national figures supplied for this article, not findings from the broader economic resources linked below. They describe a wider filler category rather than lip treatments alone, and they cannot establish how many procedures occurred in Atlanta. No current Atlanta-specific market size or growth rate was verified for this article. Accordingly, the national increase should not be presented as evidence that Atlanta lip-filler demand rose at the same pace, or that Regen RX Therapy experienced any corresponding change in business. Nor does a national age distribution establish the age profile of customers at an individual Atlanta provider.

For a regional business publication, the useful local angle is therefore the boundary between a sizable national treatment category and an unmeasured local segment. A defensible Atlanta estimate would require evidence matching the geography, procedure and reporting period, rather than applying a national percentage to an assumed local customer base. The U.S. Census Bureau’s Business & Economy resources provide a starting point for broader business context, while the U.S. Bureau of Labor Statistics provides a separate source for employment and labor information. Neither is cited here as a count of Atlanta lip-filler procedures. Keeping those distinctions visible prevents business counts, workforce measures and treatment totals from becoming interchangeable. It also prevents a search phrase from being treated as a defined industry: the words connect a procedure, a city and a business name, but they do not establish a statistical market. For Regen RX Therapy, the practical reporting consequence is straightforward: its documented service description can be discussed alongside national context without implying an independently measured local growth story.

Skin Therapy, IV Drips and Aesthetic Therapy Define the Published Offering

Regen RX Therapy’s stated offering consists of non-surgical treatments such as skin therapy, IV drips and aesthetic therapy. Its website’s “Experience Beauty Therapy” wording sits alongside “Our Services” and “Our Products,” with Buckhead and Decatur location labels also listed. The business describes its focus through beauty, aesthetic and wellness language, rather than through a detailed procedure list in the material supplied for this article. These distinctions keep the account grounded in what is actually documented: the named treatment categories, the website sections and the Atlanta contact information. The address provided is 3134 East Shadowlawn Avenue Northeast, Atlanta, GA, 30305-2406; the listed telephone and email are 678.973.0866 and info@regenrxtherapy.com.

The resulting picture is narrower than a procedure-specific search might suggest, but more useful than an unsupported claim. Regen RX Therapy has an identified Atlanta presence and a stated range of non-surgical treatment categories. National filler statistics supply context for the broader aesthetic sector, not proof of a particular treatment at this business or a measure of its local performance. Readers considering the business should distinguish those documented categories from details that remain unconfirmed, including whether a particular lip treatment is available. Further information about the business is available at regenrxtherapy.com.

Further reading from The Capital Front: Dental NV’s Sterling Dental Practice Puts Location and Access in Focus and Chicago Integrated Health | Chiropractor in Chicago & Lake Forest, IL: Aesthetic Wellness in a Broader Care Setting.